Member Info for HarChris

Does your mate still think there's a decent chance of a 1:1 rights issue at 10p a share?

BBN sums it up here succinctly: https://x.com/bigbitenow/status/1927611424819261811?s=46

$34.4m net profit for the quarter with average gold price of just $2720/oz because the hedge was being closed out... now imagine what Q2 is going to be like at an average price of close to $3300/oz.

Look at the 250K 27p sell, someone got that very wrong.

'It's good that they have the money for all these works and further development'

_____________

Yeah this is about the most positive signal we're getting at the moment. Looking at the July/August/Sept/Oct pours I suspect cash was down to the bare bones by November but here we are today, a few days from June, and there's been no raise and expansion still appears to be happening.

Are you serious? You don’t know what needs to happen?!

Operational improvements, increase production growth, clarity on the AISC etc all things that prove GRL is actually benefiting from the high gold price.

It’s not a mystery why the share price is where it is.

Not if a deal 'later this year' can fund it, let's not issue 100m+ shares down here if there's an alternative.

CC also said that funding would be tied to data.

Well personally I’d like to see a ~ £10m placing/subscription, next Heights July payment in cash plus a bit more breathing space if mgmt need to progress deal negotiations into early 2026.

So maybe 5 or 6 months time? That's far from a lifetime away and funded to that point.

I thought it was largely agreed that whilst we PIs won't get a p1b update til q4 potential partners will get access long before that, especially as we're coming up to three months since 'multiple patients dosed'? So a deal could land earlier.

Still a bit of a toss up between seeing 50p next or 20p but bust this company is not and will not.

I’m backing the former.

Following on from what I said about changing climate the other day... CYK today the fourth small cap i follow to announce a raise and be up in trading - 8% currently.

Well done on your successful trading!

Failing to get the accounts out on time followed by suspension, which happens a lot on AIM, would be a sign that all is not well. A short delay? Irrelevant.

I suspect those on the sidelines are waiting to see the selling has dried up / the bottom is in before loading up - hint, hint CLSK haha

sure, you don't find me trying to get negative comments removed or posters banned, i don't think that helps.

i still think what i said is true, most of them have pushed other aim companies instead that have performed terribly because aim is going through its worst bear market ever. they happen to be ****y on this bb whilst going quiet on others where they have lost their money.

they will continue to be right here too until they aren't and then they'll disappear.

Well it’s certainly looking highly likely the low bar for SGC and progression free survival will be improved upon, admittedly too early to say for the STS and TNBC until we get p1b data but the latter alone should unlock the valuation and fund what the management are most excited about, 6103.

We’re well into 1b now, much clearer proof of efficacy is getting ever closer.

Almost every biotech company on AIM with a valuation of say £400m and below in 2021 is considerably down over the same period. That's why there has been progress here yet decimation in the share price, not so much Avacta specific and I haven't seen much to suggest that said posters called this because they understood the broader market environment from 2021 onwards. They just happened to have the horn for Avacta but other small pharma and AIM companies they instead championed have also seen share price erosion.

As long as production starts increasing towards 1000 ounces GRL is going to be make a lot of money. The obvious risk if production has increase but isn't quite at the target is that GRL won't easily be able to meet their debt requirements by Dec 31st, but the thing that's important to remember is that that debt is sat with the largest shareholder (AIMS). It's in their interest to see GRL succeed so as long as enough progress is made they'll almost certainly renegotiate again, take some more interest and give Goldstone the space to really go at the huge potential growth over the next twelve months.

You’re deflecting. I never said that the lack of TR1 proved the biggest holders haven’t sold, I know full well they don’t play by the rules. I did however point out that we know that most of the recent large round numbered sells are a poster on here, not an II. We also know the volume has been low so it’s unlikely they have been selling.

Possible of course but unlikely, the drop is much more likely due to PIs derisking and nothing do with inside info.